HTRA2 and early-onset autosomal dominant Alzheimer disease: As a chaperone protein, HtrA2/Omi prevents the aggregation of amyloid β1-42, a major component of neurotoxic deposits in the brains of Alzheimer’s disease patients, in a protease-independent manner [16].